PUMA Welcomes AC Milan Star Theo Hernández to the Family 
Coca-Cola Launches Data-Driven Insights Platform for Retail and Foodservice Industries 
Why banks consider renewable energy to be a riskier investment than fossil fuels 
McDonald's Faces Backlash Over $5 Meal Deal: Customers Call It 'Skimpy' 
From Burger King to McDonald’s: Fast-Food Prices Surge Dramatically in Recent Years 
Semaglutide's Benefits Beyond Weight Loss: New Insights from the SELECT Trial 
Burger King Introduces Mozzarella Fries: A New Spin on an Old Favorite 
McDonald’s Rolls Out $5 Meal Deals to Emphasize Affordability Amid Rising Costs 
Cancer drug pollution is a growing global concern 
The 2023 Sir Paul Curran award for academic journalism goes to Barbara Sahakian 
How supermarkets are changing their branding to make you think they’re cheaper 
Aldi, Hy-Vee Recall Cream Cheese Products Over Potential Salmonella Contamination 
ECB Calls for Monitoring and Possible Regulation of AI in Finance 
Skepta and PUMA Launch Groundbreaking Collection 
MALVERN, Pa., April 14, 2016 -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2016 earnings on Tuesday, April 26, 2016 at 4:00 PM Eastern Time.
The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, April 26, 2016. The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com. If you are unable to participate during the live webcast, an archive will be available on our website for two weeks.
About BioTelemetry
BioTelemetry, Inc., formerly known as CardioNet, Inc., is the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care. The Company currently provides cardiac monitoring services, original equipment manufacturing with a primary focus on cardiac monitoring devices and centralized cardiac core laboratory services. More information can be found at www.gobio.com.
Contact: BioTelemetry, Inc. Heather C. Getz Investor Relations 800-908-7103 [email protected]
